The Future of Drug Delivery Innovations in Biotechnology and Biomaterials
- Type: Archived Webinar
Biomaterials and Biotechnology: From the Discovery of the First Angiogenesis Inhibitors to the Development of Controlled Drug Delivery Systems and the Foundation of Tissue Engineering
Advanced drug delivery systems are having an enormous impact on human health.
We start by discussing our early research on developing the first controlled release systems for macromolecules and the isolation of angiogenesis inhibitors and how these led to numerous new therapies. For example, new drug delivery technologies including nanoparticles and nanotechnology are now being studied for use treating cancer and other illnesses.
We then discuss ways of developing novel microchips for drug delivery. Approaches for creating new biomaterials are then evaluated and examples where such materials are used in brain cancer and shape memory applications are discussed.
Finally, by combining mammalian cells, including stem cells, with synthetic polymers, new approaches for engineering tissues are being developed that may someday help in various disease. Examples in the areas of cartilage, skin, blood vessels and spinal cord repair are discussed.
Robert S. Langer is the David H. Koch Institute Professor (being an Institute Professor is the highest honor that can be awarded to a faculty member). Dr. Langer has written nearly 1,120 articles. He also has approximately 790 issued and pending patents worldwide. Dr. Langer’s patents have been licensed or sublicensed to over 220 pharmaceutical, chemical, biotechnology and medical device companies. He is the most cited engineer in history.
He served as a member of the United States Food and Drug Administration’s SCIENCE Board, the FDA’s highest advisory board, from 1995 --...Read more
Do you already own this?
Log In for instructions on accessing this content.
|AIChE Member Credits||1|
|AIChE Undergraduate Student Members||Free|
|AIChE Graduate Student Members||Free|